| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.29M | 136.63M | 136.17M | 162.02M | 99.80M | 94.11M |
| Gross Profit | 37.89M | 41.43M | 40.88M | 55.17M | 33.09M | 30.71M |
| EBITDA | 17.04M | -6.56M | -3.69M | -55.99M | 10.27M | 8.75M |
| Net Income | 3.28M | -22.85M | -17.86M | -69.86M | -911.00K | 877.00K |
Balance Sheet | ||||||
| Total Assets | 185.52M | 180.95M | 209.97M | 226.52M | 228.10M | 207.41M |
| Cash, Cash Equivalents and Short-Term Investments | 17.20M | 17.42M | 27.43M | 26.59M | 47.60M | 37.24M |
| Total Debt | 58.15M | 59.98M | 64.54M | 70.66M | 59.82M | 62.43M |
| Total Liabilities | 89.24M | 83.63M | 91.16M | 104.02M | 91.50M | 80.27M |
| Stockholders Equity | 96.28M | 97.32M | 118.81M | 122.50M | 99.44M | 92.69M |
Cash Flow | ||||||
| Free Cash Flow | 4.75M | 8.83M | 3.72M | -13.04M | 8.53M | -19.66M |
| Operating Cash Flow | 8.51M | 10.72M | 7.20M | 16.73M | 20.20M | 2.38M |
| Investing Cash Flow | -11.76M | -16.63M | -8.40M | -59.27M | -13.68M | -22.57M |
| Financing Cash Flow | -5.86M | -3.97M | 1.74M | 25.55M | 3.77M | 48.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £1.17B | 16.42 | 15.06% | 0.74% | 39.45% | 171.03% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | £188.87M | -0.48 | -29.91% | ― | -5.85% | -413.36% | |
56 Neutral | £171.04M | -34.00 | 3.39% | ― | 1.43% | ― | |
55 Neutral | £3.30B | 28.33 | 1.69% | 6.76% | 4.51% | -24.35% | |
54 Neutral | £1.07B | 18.78 | 4.75% | 5.97% | -0.58% | -37.03% |